Circulating tissue factor and thrombosis

Current Opinion in Hematology

Volumn 7, Issue 5, 2000, Pages 273-277

  Rauch, Ursula ^a   Nemerson, Yale ^a,b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b Division of Thrombosis Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRIN; THROMBOPLASTIN;

ARTERY WALL; FIBRIN DEPOSITION; HUMAN; PRIORITY JOURNAL; REVIEW; THROMBOCYTE; THROMBOGENESIS; THROMBOGENICITY; THROMBOSIS; THROMBUS;

ANIMALS; BLOOD CIRCULATION; HUMANS; LEUKOCYTES; THROMBOPLASTIN; THROMBOSIS;

EID: 0033900083     PISSN: 10656251     EISSN: None     Source Type: Journal    
DOI: 10.1097/00062752-200009000-00003     Document Type: Review

References (50)

1. 1 Zeldis SM, Nemerson Y, Pitlick FA, et al.: Tissue factor (thromboplastin): localization to plasma membranes by peroxidase-conjugated antibodies. Science 1972, 175:766-768.
2. 2 Fuster V, Fallon JT, Badimon JJ, et al.: The unstable atherosclerotic plaque: clinical significance and therapeutic intervention. Thromb Haemost 1997, 78:247-255.
3. 3 Fuster V, Fallon JT, Nemerson Y: Coronary thrombosis. Lancet 1996, 348 Suppl 1:s7-10.
4. 4 Giesen PL, Rauch U, Bohrmann B, et al.: Blood-borne tissue factor: another view of thrombosis. Proc Natl Acad Sci U S A 1999, 96:2311-2315. This paper documents the TF-dependence of ex vivo thrombus formation and the presence of TF antigen in spontaneous human thrombi.
5. 5 Rauch U, Bonderman D, Bohrmann B, et al.: Transfer of tissue factor from leukocytes to platelets is mediated via CD15 and tissue factor. Blood 2000, 96:170-175. This review demonstrates that leukocytes can transfer TF to platelet surfaces and that TF andCD15 coexist on a PMN pseudopod contacting a platelet.
6. 6 Nemerson Y: Tissue factor and hemostasis. Blood 1988, 71:1-8.
7. 7 Banner DW, D'Arcy A, Chene C, et al.: The crustal structure of the complex of blood coagulation factor VIIa with soluble tissue factor. Nature 1996, 380:41-46.
8. 8 Nelsestuen GL: Enhancement of vitamin-K-dependent protein function by modification of the gamma carboxyglutamic acid domain: studies of protein C and factor VII. Trends Cardiovasc Med 1999, 9:162-167.
9. 9 Key NS, Slungaard A, Dandelet L, et al.: Whole blood tissue factor procoagulant activity is elevated in patients with sickle cell disease. Blood 1998, 91;4216-4223.
10. 10 Suefuji H, Ogawa H, Yasue H, et al.: Increased plasma tissue factor levels in acute myocardial infarction. Am Heart J 1997, 134:253-259.
11. 11 Gando, S, Nanzaki S, Sasaki S, et al.: Activation of the extrinsic coagulation pathway in patients with severe sepsis and septic shock. Crit Care Med 1998, 26;2005-2009.
12. 12 Amengual O, Atsumi T, Khamashta MA, et al.: The role of the tissue factor pathway in the hypercoagulable state in patients with the antiphospholipid syndrome. Thromb Haemost 1998, 79:276-281.
13. 13 Asakura H, Kamikubo Y, Goto A, et al.: Role of tissue factor in disseminated intravascular coagulation. Thromb Res 1995, 80;217-224.
14. 14 Gando S, Nanzaki S, Sasaki S, et al.: Significant correlations between tissue factor and thrombin markers in trauma and septic patients with disseminated intravascular coagulation. Thromb Haemost 1998, 79:1111-1115.
15. 15 Carey MJ, Rodgers GM: Disseminated intravascular coagulation: clinical and laboratory aspects. Am J Hematol 1998, 59:65-73.
16. 16 Hugel B, Socie G, Vu T, et al.: Elevated levels of circulating procoagulant microparticles in patients with paroxysmal nocturnal hemoglobunuria and aplastic anemia. Blood 1999, 93:3451-3456. This review documents the presence of procoagulant microparticles in the circulation. These particles are shown to support prothombinase activity.
17. 17 Mallat Z, Benamer H, Hugel B, et al: Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. Circulation 2000, 101:841-843. Microparticles are shown in the blood of patients with acute coronary syndromes, and this report points to endothelial cells as their source.
18. 18 Schecter AD, Giesen PL, Taby O, et al.: Tissue factor expression in human arterial smooth muscle cells: TF is present in three cellular pools after growth factor stimulation. J Clin Invest 1997, 100:22760-22785.
19. 19 Conkling PR, Greenberg CS, Weinberg JB: Tumor necrosis factor induces tissue factor-like activity in human leukemia cell line U937 and peripheral blood monocytes. Blood 1988, 72:128-133.
20. 20 Schonbeck U, Mach F, Sukhova GK, et al.: CD40 ligation induces tissue factor expression in human vascular smooth muscle cells. Am J Pathol 2000, 156:7-14. These authors show that engagement of CD40 on smooth muscle cells induces TF synthesis.
21. 21 Toschi, V, Gallo R, Lettino M, et al.: Tissue factor modulates the thrombogenicity of human atherosclerotic plaques. Circulation 1997, 95:594-599.
22. 22 Mallat Z, Hugel B, Ohan J, et al.: Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: a role for apoptosis in plaque thrombogenicity. Circulation 1999, 99:348-353. Microparticles within atherosclerotic plaques can be extracted. The data presented point to apoptosis as the mechanism involved in their formation.
23. 23 Lewis JC, Bennett-Cain AL, DeMars CS, et al.: Procoagulant activity after exposure of monocyte-derived macrophages to minimally oxidized low density lipoprotein: co-localization of tissue factor antigen and nascent fibrin fibers at the cell surface. Am J Pathol 1995, 147:1029-1040.
24. 24 Kirchhofer D, Riederer MA, Baumgartner HR: Specific accumulation of circulating monocytes and polymorphonuclear leukocytes on platelet thrombi in a vascular injury model. Blood 1997, 89:1270-1278.
25. 25 Niemetz J, Marcus AJ: The stimulatory effect of platelets and platelet membranes on the procoagulant activity of leukocytes. J Clin Invest 1974, 54:1437-1443.
26. 26 Halvorsen H, Olsen JO, Osterud B: Granulocytes enhance LPS-induced tissue factor activity in monocytes via an interaction with platelets. J Leukoc Biol 1993, 54:275-282.
27. 27 Todoroki, H, Higure A, Okamoto K, et al.: Possible role of platelet-activating factor in the in vivo expression of tissue factor in neutrophils. J Surg Res 1998, 80:149-155.
28. 28 Bach R, Rifkin DB: Expression of tissue factor procoagulant activity: regulation by cytosolic calcium. Proc Natl Acad Sci U S A 1990, 87:6995-6999
29. 29 Maynard JR, Heckman CA, Pitlick FA, et al.: Association of tissue factor activity with the surface of cultured cells. J Clin Invest 1975, 55:814-824.
30. 30 Berg H: Random Walks in Biology. Princeton, NJ: Princeton University Press; 1993.
31. 31 Harker LA, Hanson SR, Kelly AB: Antithrombotic strategies targeting thrombin activities, thrombin receptors and thrombin generation. Thromb Haemost 1997, 78:736-741.
32. 32 Larsen E, Palabrica T, Sajer S, et al.: PADGEM-dependent adhesion of platelets to monocytes and neutrophils is mediated by a lineage-specific carbohydrate, LNF III (CD15). Cell 1990, 63:467-474.
33. 33 Johnston GI, Cook RG, McEver RP: Cloning of GMP-140, a granule membrane protein of platelets and endothelium: sequence similarity to proteins involved in cell adhesion and inflammation. Cell 1989, 56:1033-1044.
34. 34 McEver RP, Moore KL, Cummings RD: Leukocyte trafficking mediated by selectin-carbohydrate interactions. J Biol Chem 1995, 270:11025-11048.
35. 35 Vestweber D, Blanks JE: Mechanisms that regulate the function of the selectins and their ligands. Physiol Rev 1999, 79:181-213. This is a complete review of the mechanisms involved in the interaction of selectins with their ligands.
36. 36 Ikeda, H, Ueyama T, Murohara T, et al.: Adhesive interaction between P-selectin and sialyl Lewis(x) plays an important role in recurrent coronary arterial thrombosis in dogs. Arterioscler Thromb Vasc Biol 1999, 19:1083-1090.
37. 37 Barron MK, Lake RS, Buda AJ, et al.: Intimal hyperplasia after balloon injury is attenuated by blocking selectins. Circulation 1997, 96:3587-3592.
38. 38 Palabrica T, Lobb R, Furie BC, et al.: Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets. Nature 1992, 359:848-851.
39. 39 Subramaniam M, Frenette PS, Saffaripour S, et al.: Defects in hemostasis in P-selectin-deficient mice. Blood 1996, 87:1238-1242.
40. 40 Kumar A, Villani MP, Patel UK, et al.: Recombinant soluble form of PSGL-1 accelerates thrombolysis and prevents reocclusion in a porcine model. Circulation 1999, 99:1363-1369.
41. 41 Randolph GJ, Luther T, Albrecht S, et al.: Role of tissue factor in adhesion of mononuclear phagocytes to and trafficking through endothelium in vitro. Blood 1998, 92:4167-4177.
42. 42 Muller M, Albrecht S, Golfert F, et al.: Localization of tissue factor in actin-filament-rich membrane areas of epithelial cells. Exp Cell Res 1999, 248:136-147.
43. 43 Ott I, Fischer EG, Miyagi Y, et al.: A role for tissue factor in cell adhesion and migration mediated by interaction with actin-binding protein 280. J Cell Biol 1998, 140:1241-1253.
44. 44 Fischer EG, Riewald M, Huang HY, et al.: Tumor cell adhesion and migration supported by interaction of a receptor-protease complex with its inhibitor. J Clin Invest 1999, 104;1213-1221.
45. 45 Badimon JJ, Lettino M, Toschi V, et al.: effects of tissue factor pathway inhibitor on plaque thrombogenicity under flow conditions. Circulation 1999, 99:1780-1787. This study shows that tissue factor pathway inhibitor reduces the amount of thrombus deposited on perfused human arterial segments, thus implicating tissue factor in the vessel wall as a thrombogenic species.
46. 46 Abendschein DR, Meng YY, Torr-Brown S, et al.: Maintenance of coronary patency after fibrinolysis with tissue factor pathway inhibitor. Circulation 1995, 92:944-949.
47. 47 Arnljots, B, Ezban M, Hedner U: Prevention of experimental arterial thrombosis by topical administration of active site-inactivated factor VIIa. J Vasc Surg 1997, 25:341-346.
48. 48 Golino P, Ragni M, Cirillo P, et al.: Antithrombotic effects of recombinant human, active site-blocked factor VIIa in a rabbit model of recurrent arterial thrombosis. Circ Res 1998, 82:39-46.
49. 49 Himber J, Kirchhofer D, Riederer M, et al.: Dissociation of antithrombotic effect and bleeding time prolongation in rabbits by inhibiting tissue factor function. Thromb Haemost 1997, 78:1142-1149.
50. 50 Harker LA, Hanson SR, Wilcox JN, et al.: Antithrombotic and antilesion benefits without hemorrhagic risks by inhibiting tissue factor pathway. Haemostasis 1996, 26:76-82.